MX2020002231A - Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas. - Google Patents
Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas.Info
- Publication number
- MX2020002231A MX2020002231A MX2020002231A MX2020002231A MX2020002231A MX 2020002231 A MX2020002231 A MX 2020002231A MX 2020002231 A MX2020002231 A MX 2020002231A MX 2020002231 A MX2020002231 A MX 2020002231A MX 2020002231 A MX2020002231 A MX 2020002231A
- Authority
- MX
- Mexico
- Prior art keywords
- anesthetic
- amide
- type
- preparing
- methods
- Prior art date
Links
- 230000003444 anaesthetic effect Effects 0.000 title abstract 9
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
- 150000002632 lipids Chemical group 0.000 abstract 2
- 239000012062 aqueous buffer Substances 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se provee una composición anestésica para administrar localmente un anestésico tipo amida en un sujeto en necesidad de la misma; la composición anestésica tiene vesículas multilaminares con anestésico tipo amida atrapado preparado hidratando una estructura de lípidos altamente atrapada que comprende un anestésico tipo amida y una mezcla de lípidos con una solución de regulador de pH acuoso a un pH mayor de 5.5; se provee también un método para preparar una composición anestésica usando un procedimiento más simple y más factible para la fabricación a gran escala y para proveer una alta relación molar de contenido de anestésico tipo amida a fosfolípido en comparación con la técnica anterior; esta composición anestésica tiene una duración de eficacia prolongada adaptada al suministro de fármacos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762550983P | 2017-08-28 | 2017-08-28 | |
| US201862621730P | 2018-01-25 | 2018-01-25 | |
| PCT/US2018/048329 WO2019046293A1 (en) | 2017-08-28 | 2018-08-28 | EXTENDED RELEASE ANESTHETIC COMPOSITIONS AND METHODS OF PREPARATION THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2020002231A true MX2020002231A (es) | 2022-06-14 |
| MX393126B MX393126B (es) | 2025-03-24 |
Family
ID=63668016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020002231A MX393126B (es) | 2017-08-28 | 2018-08-28 | Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US11793799B2 (es) |
| EP (1) | EP3675816B1 (es) |
| JP (1) | JP7173615B2 (es) |
| KR (2) | KR102800917B1 (es) |
| CN (2) | CN118105349A (es) |
| AU (2) | AU2018323436B2 (es) |
| BR (1) | BR112020003743A2 (es) |
| CA (1) | CA3073734A1 (es) |
| CY (1) | CY1126137T1 (es) |
| DK (1) | DK3675816T3 (es) |
| ES (1) | ES2946919T3 (es) |
| FI (1) | FI3675816T3 (es) |
| HR (1) | HRP20230535T1 (es) |
| HU (1) | HUE062202T2 (es) |
| LT (1) | LT3675816T (es) |
| MX (1) | MX393126B (es) |
| PL (1) | PL3675816T3 (es) |
| PT (1) | PT3675816T (es) |
| RS (1) | RS64297B1 (es) |
| SI (1) | SI3675816T1 (es) |
| SM (1) | SMT202300163T1 (es) |
| TW (1) | TWI806894B (es) |
| WO (1) | WO2019046293A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7173615B2 (ja) * | 2017-08-28 | 2022-11-16 | ティーエルシー バイオファーマシューティカルズ、インク． | 徐放性麻酔組成物及びその調製方法 |
| JP7366916B2 (ja) * | 2018-03-30 | 2023-10-23 | ティーエルシー バイオファーマシューティカルズ、インク． | 徐放性麻酔剤組成物およびその調製方法 |
| AU2020229773B2 (en) | 2019-02-26 | 2025-04-03 | Tlc Biopharmaceuticals, Inc. | Pharmaceutical compositions for use in treating pain |
| US20220249375A1 (en) | 2019-06-28 | 2022-08-11 | Jiangsu Hengrui Medicine Co., Ltd. | Sustained-release lipid composition and preparation method therefor |
| CN113116823B (zh) * | 2019-12-30 | 2024-02-20 | 江苏恒瑞医药股份有限公司 | 一种脂质体及其制备方法 |
| EP4091612B1 (en) | 2020-01-14 | 2025-11-12 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences | Long-acting ropivacaine pharmaceutical composition, preparation method therefor and use thereof |
| CN114668723A (zh) * | 2020-12-25 | 2022-06-28 | 江苏恒瑞医药股份有限公司 | 一种含有局部麻醉药的脂质体及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244678A (en) | 1986-01-14 | 1993-09-14 | Ire-Celltarg S.A. | Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes |
| FR2592791A1 (fr) * | 1986-01-14 | 1987-07-17 | Ire Celltarg Sa | Composition pharmaceutique, contenant un anesthesique local et/ou un analgesique central encapsule dans des liposomes |
| US5227165A (en) * | 1989-11-13 | 1993-07-13 | Nova Pharmaceutical Corporation | Liposphere delivery systems for local anesthetics |
| GB9605915D0 (en) * | 1996-03-21 | 1996-05-22 | Univ Bruxelles | Liposome encapsulated amphiphilic drug compositions |
| GB9609779D0 (en) | 1996-05-10 | 1996-07-17 | Univ Bruxelles | Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof |
| EP2308470A1 (en) | 1997-09-18 | 2011-04-13 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| WO1999049849A1 (en) | 1998-03-31 | 1999-10-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal bupivacaine compositions and methods of preparation |
| ATE355827T1 (de) | 1998-08-12 | 2007-03-15 | Yissum Res Dev Co | Mittels ammoniumsulfatgradient hergestellte liposomale therapeutische zusammensetzungen |
| HRP20130328T1 (hr) | 2006-10-06 | 2013-05-31 | Scil Technology Gmbh | Formiranje osušene rekonstituirane vezikule za farmaceutsku primjenu |
| JPWO2013146386A1 (ja) * | 2012-03-27 | 2015-12-10 | 学校法人関西医科大学 | 局所麻酔薬持続性徐放製剤 |
| TW201427447A (zh) | 2012-09-17 | 2014-07-01 | Interdigital Patent Holdings | 回載無線電資源及小胞元回載延遲估計自我最佳化 |
| WO2014046191A1 (ja) * | 2012-09-21 | 2014-03-27 | テルモ株式会社 | 局所麻酔薬持続徐放性リポソーム製剤 |
| CN103142458B (zh) * | 2013-01-22 | 2015-09-09 | 莱普德制药有限公司 | 无成瘾性镇痛缓释递药系统的组方与制备方法 |
| US11083730B2 (en) | 2014-04-21 | 2021-08-10 | Heron Therapeutics, Inc. | Long-acting polymeric delivery systems |
| JP7173615B2 (ja) * | 2017-08-28 | 2022-11-16 | ティーエルシー バイオファーマシューティカルズ、インク． | 徐放性麻酔組成物及びその調製方法 |
-
2018
- 2018-08-28 JP JP2020511474A patent/JP7173615B2/ja active Active
- 2018-08-28 HU HUE18773692A patent/HUE062202T2/hu unknown
- 2018-08-28 PL PL18773692.1T patent/PL3675816T3/pl unknown
- 2018-08-28 ES ES18773692T patent/ES2946919T3/es active Active
- 2018-08-28 EP EP18773692.1A patent/EP3675816B1/en active Active
- 2018-08-28 CN CN202410245391.7A patent/CN118105349A/zh active Pending
- 2018-08-28 SM SM20230163T patent/SMT202300163T1/it unknown
- 2018-08-28 CN CN201880055567.5A patent/CN111182889A/zh active Pending
- 2018-08-28 US US16/642,762 patent/US11793799B2/en active Active
- 2018-08-28 RS RS20230409A patent/RS64297B1/sr unknown
- 2018-08-28 KR KR1020207008714A patent/KR102800917B1/ko active Active
- 2018-08-28 LT LTEPPCT/US2018/048329T patent/LT3675816T/lt unknown
- 2018-08-28 CA CA3073734A patent/CA3073734A1/en active Pending
- 2018-08-28 HR HRP20230535TT patent/HRP20230535T1/hr unknown
- 2018-08-28 AU AU2018323436A patent/AU2018323436B2/en active Active
- 2018-08-28 WO PCT/US2018/048329 patent/WO2019046293A1/en not_active Ceased
- 2018-08-28 PT PT187736921T patent/PT3675816T/pt unknown
- 2018-08-28 TW TW107130015A patent/TWI806894B/zh active
- 2018-08-28 KR KR1020257001950A patent/KR20250029892A/ko active Pending
- 2018-08-28 BR BR112020003743-5A patent/BR112020003743A2/pt active IP Right Grant
- 2018-08-28 SI SI201830921T patent/SI3675816T1/sl unknown
- 2018-08-28 MX MX2020002231A patent/MX393126B/es unknown
- 2018-08-28 DK DK18773692.1T patent/DK3675816T3/da active
- 2018-08-28 FI FIEP18773692.1T patent/FI3675816T3/fi active
-
2023
- 2023-06-19 CY CY20231100287T patent/CY1126137T1/el unknown
- 2023-09-13 US US18/466,226 patent/US12280043B2/en active Active
- 2023-11-14 AU AU2023266253A patent/AU2023266253B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020002231A (es) | Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas. | |
| EA202191559A1 (ru) | Модифицированные аминовые липиды | |
| MX386820B (es) | Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología. | |
| MX2023012225A (es) | Composiciones anestesicas de liberacion sostenida y metodos de preparacion de las mismas. | |
| BR112013017382A2 (pt) | métodos para preparação de glicoesfingolipídios e usos destes | |
| EA201490395A1 (ru) | Способ получения фармацевтических композиций, содержащих финголимод | |
| MY184381A (en) | Stable formulations of lipids and liposomes | |
| BR112013015732A2 (pt) | processo para a preparação de uma solução aquosa estável de dióxido de cloro. | |
| AR086237A1 (es) | FORMULACION PARA ANTICUERPO ANTI-a4b7 | |
| AU2013334740A8 (en) | Stable, low viscosity antibody formulation | |
| MX391077B (es) | Composiciones de fenfluramina y métodos de preparación de las mismas. | |
| MX390947B (es) | Composiciones terapéuticas de ceramidasa ácida y métodos para prepararlas y utilizarlas. | |
| BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
| MX2011011871A (es) | Formulacion intravenosa con cocristales solubles en agua de acido acetilisalicilico y teanina. | |
| MX2012000372A (es) | Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas. | |
| AR112536A1 (es) | Métodos para reducir la formación de partículas y composiciones elaboradas a través de los mismos | |
| PH12017500136A1 (en) | Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof | |
| MX364800B (es) | Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca. | |
| EP4282272A3 (en) | Method of delivering an agriculturally active ingredient | |
| EA201490363A1 (ru) | Новые составы на основе (триметоксифениламино)пиримидинилов | |
| TN2012000436A1 (en) | Agomelatine hydrobromide hydrate and preparation thereof | |
| UA113058C2 (xx) | Кристалічна форма vii агомелатину, спосіб її приготування і застосування і фармацевтична композиція, яка її містить | |
| EA201491174A1 (ru) | Косметические композиции масло-в-воде | |
| WO2012068998A3 (zh) | 一种曲安奈德眼用制剂及其制备方法 | |
| ATE516015T1 (de) | Galenische form zur oralen transmukosalen zuführung von triptanen |